Dr Kimambo welcomed as new acting Country Representative to Kenya

NairobiDr Neema Rusibamayila Kimambo, the new acting WHO Representative to Kenya, held her first official meeting with Cabinet Secretary for Health Honourable Aden Duale on 4 February 2026. The meeting set the agenda for 2026 and reaffirmed WHO's commitment to supporting the Ministry of Health.

Improving lives of people affected by lymphatic filariasis in Kenya

Nairobi—Kenya is accelerating efforts to eliminate lymphatic filariasis, commonly known as elephantiasis, as a public health problem by 2027. Yearly mass drug administration carried out between 2016 and 2022 have effectively halted transmission of the disease—a painful and disfiguring mosquito-borne infection that can cause permanent disability.

Protecting communities to eliminate lymphatic filariasis in Kenya

NairobiIn Kenya, regular mass drug administration is protecting a new generation from the effects of lymphatic filariasis, commonly known as elephantiasis ‒ a neglected tropical disease that affects the lymphatic system and can lead to the abnormal enlargement of body parts, causing pain, severe disability and social stigma.

Kenya’s third oral cholera vaccine campaign protects thousands in Narok County

Narok County—Cholera remains a significant public health concern in Kenya. Since 1 October 2025, over 231 cases and 13 deaths were reported across three counties, including Narok, one of the hardest hit. To curb transmission, the Ministry of Health, with support from the World Health Organization (WHO), the Kenya National Public Health Institute, the Kenya Red Cross Society and Médecins Sans Frontières, conducted a reactive oral cholera vaccine campaign in Transmara West and Transmara South, targeting residents aged one year and above.